Clinical Trial Update: 9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating 9MW2821 in combination with other antitumor drugs for advanced gynecologic cancers; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• 9MW2821

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Gynecological Malignancies | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING